Article Details
Retrieved on: 2021-09-19 11:26:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
With the MONALEESA-2 final analysis, only Kisqali has reported statistically significant overall survival (OS) benefit with an aromatase inhibitor for ...
Article found on: finance.yahoo.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here